-
Advanced imaging in the modern era of prostate cancer_Ashesh Jani, MD, MSEE, FASTRO; #DDHO2021
2:54
-
Addressing Disparities in Cancer Care and Incorporating Precision Medicine for Minority Populations: Prostate Cancer_Arthur L. Burnett, MD, MBA, FACS_Yaw Nyame, MD.
50:53
-
Neal Shore, MD, FACS; Carolina Urologic Research Center 5Live #ASCO20
4:58
Key Insights on HERO phase III trial: Results comparing relugolix, an oral GnRH receptor antagonist, versus leuprolide acetate for advanced prostate cancer.
-
Expert Insights_New Treatments and New Targets for the Treatment of Prostate Cancer: Expanding Options Along the Disease Continuum
29:35
ABOUT
Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.
The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.
CONNECT
© Copyright 2021 Bio Ascend, a Vaniam Group company